Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System
ArtivionArtivion(US:AORT) Businesswire·2026-05-18 19:05

公司动态 - Artivion公司已完成对Endospan公司的收购交易 [1] - Endospan公司是治疗复杂主动脉病变的血管内解决方案领域的先驱 [1] 产品与监管 - Endospan公司的NEXUS主动脉弓系统于2026年4月获得了美国FDA的上市前批准 [1] - 该产品是首个用于治疗主动脉弓疾病的即用型血管内解决方案，适用于包括慢性主动脉夹层在内的高风险患者 [1]

Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System - Reportify